Rugiet Health vs MEDVi Quad

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

Rugiet Health vs MEDVi Quad: Overview

Choosing between Rugiet Health and MEDVi Quad for GLP-1 weight loss medication? Both are popular providers, but they differ in pricing, medication options, and service features.

Rugiet Health offers both semaglutide and tirzepatide at $87/month with a rating of 7.6/10. MEDVi Quad also provides both semaglutide and tirzepatide at $114/month with a 6.5/10 rating.

With only a $27/month price difference, your choice will likely come down to features, support quality, and medication options.

VERIFIED

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

At a glance

Price Difference
$27/mo
Rating Difference
1.1
Winner
Rugiet Health
Best For
Budget

Rugiet Health

View full Rugiet Health review →
Rating
7.6/10Better
Monthly Price
$87Cheaper
Medications
sildenafiltadalafilapomorphineparoxetineenclomiphene

Pros

  • The compounded disclosure is exactly right and sits on the product page itself: 'Ready is a compounded drug product and requires a prescription. Compounded drugs are not approved by FDA and do not undergo review or verification by FDA for safety, effectiveness, or quality.' This is the clearest regulatory statement we have seen from any compounded-medication brand
  • A named nine-person Medical Advisory Board, mostly board-certified urologists, plus a named Chief Medical Officer - real, checkable clinical governance rather than an anonymous 'medical team'
  • Roughly 2,000 Trustpilot reviews at 4.3, with 100% of negative reviews answered, typically inside 24 hours
  • It publishes its own pricing article stating Ready starts at $7.29 per dose, and explains that the exact figure depends on the concentration prescribed (checked July 28, 2026)
  • Efficacy claims carry disclosed methodology - the onset figure is footnoted to a survey of 101 customers and another to 114 active patients in May 2025. The samples are small, but the sourcing is stated rather than hidden
  • Enclomiphene is marked 'Labs Required', so at least one product line has a genuine bloodwork gate rather than symptom-only prescribing
  • It states plainly that most insurance does not cover compounded medications, instead of implying coverage might apply
  • HSA/FSA eligible, free doctor consultation and shipping included, and a mobile app is available
  • Published phone support Monday to Friday plus Saturday hours, which is broader than most competitors

Cons

  • Ready stacks two PDE5 inhibitors - sildenafil and tadalafil - in a single dose, alongside apomorphine. No FDA-approved product combines two PDE5 inhibitors, and doubling the same mechanism compounds the blood-pressure-lowering effect without established additional benefit
  • Apomorphine is a dopamine agonist whose US approval is for 'off' episodes in advanced Parkinson's disease. Using it for arousal is off-label, and it independently causes nausea, low blood pressure and sudden sleep onset - risks that stack with the two PDE5 inhibitors
  • No price appears anywhere on the product pages, the treatment catalogue or the intake funnel. The only published figure sits in a blog post, so a shopper following the normal path has to create an account before learning what anything costs
  • Pricing is per dose rather than a flat monthly fee, so the monthly figure shown here reflects 12 doses at the $7.29 starting rate for comparison against similarly sold products. Your real cost depends on the concentration prescribed and how often you use it
  • 'Up to 3x the power of generics' and 'delivers stronger, more reliable results than sildenafil or tadalafil alone' are comparative efficacy claims with no trial cited
  • The headline results - 85% feeling more confident, 80% preferring Rugiet - come from internal surveys of around 101 to 114 of the company's own customers, not controlled studies
  • Go Long combines paroxetine, an SSRI, with ED medication for premature ejaculation. SSRIs are used off-label for this, and paroxetine carries its own discontinuation and sexual side-effect profile
  • The '500k+ men choose Rugiet' figure is the company's own with no independent corroboration
  • Anyone taking nitrates or riociguat must not use these products, and the apomorphine component adds a serious interaction with 5-HT3 anti-emetics such as ondansetron
Choose Rugiet Health

MEDVi Quad

View full MEDVi Quad review →
Rating
6.5/10
Monthly Price
$114
Medications
sildenafiltadalafilbremelanotide (PT-141)L-citrulline

Pros

  • $114/month, reduced from a stated $179, and the price is all-in: doctor consultation, free rush shipping and 24/7 medical support are included with no separate consultation fee (checked July 28, 2026)
  • Cancel anytime, and the page states you are not charged if you do not qualify
  • All four active ingredients are named openly - PT-141 (bremelanotide), L-citrulline, sildenafil and tadalafil - rather than hidden behind a proprietary blend name
  • Sublingual delivery is a real advantage over tablets: it bypasses first-pass metabolism, so onset is faster and a heavy meal does not blunt absorption the way it can with oral sildenafil
  • Backed by a substantial independent review record - roughly 14,000 Trustpilot reviews at 4.4, with 99% of negative reviews answered
  • A published phone number, email address and physical address, which many competitors in this category omit entirely

Cons

  • 'Peak rigidity guaranteed' appears directly in the product copy. No prescription medication can guarantee an outcome, and this is the most explicit outcome promise we have seen across every provider reviewed on this site
  • The formula stacks two PDE5 inhibitors - sildenafil and tadalafil - and then adds L-citrulline, a nitric oxide precursor. All three act on the same nitric oxide and cGMP pathway, so the blood-pressure-lowering effect compounds three ways rather than one
  • PT-141 adds a fourth agent that independently causes low blood pressure, nausea and flushing. Four actives, four routes to hypotension, and no discussion anywhere on the page of the combined risk
  • Bremelanotide's only FDA approval is as Vyleesi, an autoinjector for premenopausal women with hypoactive sexual desire disorder. Prescribing it to men in a compounded sublingual liquid is off-label and a different route of administration
  • The word FDA does not appear on the page at all. The product is compounded, and the page never states the consequence - that compounded preparations are not reviewed or approved by the FDA for safety, efficacy or quality
  • 'The world's first 4-in-1 formula' and 'hospital-grade power' are unverifiable marketing superlatives attached to a prescription product
  • The advertised Trustpilot score covers MEDVi's business as a whole rather than this specific product
  • The published address is a suite at a Delaware registered-agent building, not a clinical facility
  • Anyone taking nitrates or riociguat must not use this product. The PT-141 component also interacts with 5-HT3 anti-emetics such as ondansetron, and stacking two PDE5 inhibitors makes the nitrate contraindication more dangerous, not less
Choose MEDVi Quad

Feature-by-feature comparison

FeatureRugiet HealthMEDVi Quad
Monthly Price$87$114
Rating7.6/106.5/10
Medicationssildenafil, tadalafil, apomorphine, paroxetine, enclomiphenesildenafil, tadalafil, bremelanotide (PT-141), L-citrulline
Insurance AcceptedNoNo
Support HoursMonday to Friday 8:30am-5:30pm CT, Saturday 11am-4pm CT24/7 medical support advertised
Live ChatNoNo
Free ShippingYesYes
Shipping SpeedDiscreet delivery; free shipping included in subscription plansFree rush shipping included in the monthly price
Mobile AppAvailableNo
Dedicated CoachNot includedNot included
Follow-up FrequencyOngoing provider access through the platform and app; cadence not published24/7 medical support advertised; follow-up cadence not published
Money-back GuaranteeNone publishedNo charge if you do not qualify; no refund policy published for dispensed medication
Cancellation PolicySubscription based; buy 2 months of Ready and get the 3rd free promotion running at time of reviewCancel anytime

Which should you choose?

Choose Rugiet Health if you:

  • Want to save $27/month with a more affordable option
  • Prefer a higher-rated service (7.6/10 vs 6.5/10)
  • Want more medication options to choose from
  • Value: the compounded disclosure is exactly right and sits on the product page itself: 'ready is a compounded drug product and requires a prescription. compounded drugs are not approved by fda and do not undergo review or verification by fda for safety, effectiveness, or quality.' this is the clearest regulatory statement we have seen from any compounded-medication brand

Choose MEDVi Quad if you:

  • Value: $114/month, reduced from a stated $179, and the price is all-in: doctor consultation, free rush shipping and 24/7 medical support are included with no separate consultation fee (checked july 28, 2026)

Website previews

Rugiet Health

Rugiet Health website

MEDVi Quad

MEDVi Quad website

Our recommendation

Rugiet Health comes out ahead with a higher rating of 7.6/10. It also provides multiple medication options including both semaglutide and tirzepatide.
Get started with Rugiet Health

Compare other providers

Compare GLP-1 Brands